(Q50582897)

16 March 2018

title

Interferon-alpha2b induction treatment with or without ribavirin in chronic hepatitis C: a multicenter, randomized, controlled trial. (English)

1 reference

16 March 2018

multicenter clinical trial

main subject

1 reference

1 reference

1 reference

Hakan Senturk

1

1 reference

16 March 2018

Galip Ersoz

2

1 reference

16 March 2018

Resat Ozaras

3

1 reference

16 March 2018

Sabahattin Kaymakoglu

4

1 reference

16 March 2018

Hakan Bozkaya

5

1 reference

16 March 2018

Meral Akdogan

6

1 reference

16 March 2018

Ali Mert

7

1 reference

16 March 2018

Mithat Bozdayi

8

1 reference

16 March 2018

Fehmi Tabak

9

1 reference

16 March 2018

Necati Yenice

10

1 reference

16 March 2018

Gulsen Ozbay

11

1 reference

16 March 2018

publication date

1 June 2003

1 reference

16 March 2018

Digestive Diseases and Sciences

published in

1 reference

16 March 2018

volume

48

1 reference

16 March 2018

issue

6

1 reference

16 March 2018

page(s)

1124-1129

1 reference

16 March 2018

High-Dose interferon-alpha2b plus ribavirin for retreatment of interferon-nonresponsive patients infected with genotype 1 hepatitis C virus.

cites work

1 reference

12 December 2020

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

12 December 2020

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

12 December 2020

Multicenter randomized study comparing initial daily induction with high dose lymphoblastoid interferon vs. standard interferon treatment for chronic hepatitis C.

1 reference

12 December 2020

Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover

1 reference

12 December 2020

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

1 reference

12 December 2020

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

12 December 2020

Hepatitis C virus (HCV) RNA determination after two weeks of induction interferon treatment is an accurate predictor of nonresponse: comparison of two treatment schedules.

1 reference

12 December 2020

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

12 December 2020

Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre study

1 reference

12 December 2020

Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo

1 reference

12 December 2020

Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis C.

1 reference

12 December 2020

Combination of interferon induction therapy and ribavirin in chronic hepatitis C.

1 reference

12 December 2020

Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants

1 reference

12 December 2020

A randomized trial of high-dose interferon alpha-2b, with or without ribavirin, in chronic hepatitis C patients who have not responded to standard dose interferon.

1 reference

12 December 2020

Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study

1 reference

12 December 2020

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

12 December 2020

Efficacy of daily induction dosing vs standard thrice weekly dosing of interferon-alpha2B for initial treatment of chronic hepatitis C.

1 reference

12 December 2020

The importance of initial daily administration of interferon alpha for the eradication of hepatitis C virus in patients with chronic hepatitis C: a multicenter randomized trial.

1 reference

12 December 2020

Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1023725014751

1 reference

16 March 2018

Dimensions Publication ID

1021608634

0 references

1 reference

16 March 2018